These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1179 related articles for article (PubMed ID: 17676045)
21. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469 [TBL] [Abstract][Full Text] [Related]
22. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914 [TBL] [Abstract][Full Text] [Related]
23. IL-1beta and IL-2 convert human Treg into T(H)17 cells. Deknuydt F; Bioley G; Valmori D; Ayyoub M Clin Immunol; 2009 May; 131(2):298-307. PubMed ID: 19211307 [TBL] [Abstract][Full Text] [Related]
24. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306 [TBL] [Abstract][Full Text] [Related]
25. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Zhou L; Ivanov II; Spolski R; Min R; Shenderov K; Egawa T; Levy DE; Leonard WJ; Littman DR Nat Immunol; 2007 Sep; 8(9):967-74. PubMed ID: 17581537 [TBL] [Abstract][Full Text] [Related]
26. T-cell subsets: the more the merrier. Weaver CT; Murphy KM Curr Biol; 2007 Jan; 17(2):R61-3. PubMed ID: 17240331 [TBL] [Abstract][Full Text] [Related]
27. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Cardoso CR; Garlet GP; Crippa GE; Rosa AL; Júnior WM; Rossi MA; Silva JS Oral Microbiol Immunol; 2009 Feb; 24(1):1-6. PubMed ID: 19121062 [TBL] [Abstract][Full Text] [Related]
28. Regulation of gut inflammation and th17 cell response by interleukin-21. Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085 [TBL] [Abstract][Full Text] [Related]
29. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nurieva R; Yang XO; Martinez G; Zhang Y; Panopoulos AD; Ma L; Schluns K; Tian Q; Watowich SS; Jetten AM; Dong C Nature; 2007 Jul; 448(7152):480-3. PubMed ID: 17581589 [TBL] [Abstract][Full Text] [Related]
30. T(H)-17 cells in the circle of immunity and autoimmunity. Bettelli E; Oukka M; Kuchroo VK Nat Immunol; 2007 Apr; 8(4):345-50. PubMed ID: 17375096 [TBL] [Abstract][Full Text] [Related]
31. IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells. Hebel K; Rudolph M; Kosak B; Chang HD; Butzmann J; Brunner-Weinzierl MC J Immunol; 2011 Dec; 187(11):5627-35. PubMed ID: 22048775 [TBL] [Abstract][Full Text] [Related]
32. Rapid ex vivo isolation and long-term culture of human Th17 cells. Streeck H; Cohen KW; Jolin JS; Brockman MA; Meier A; Power KA; Waring MT; Alter G; Altfeld M J Immunol Methods; 2008 Apr; 333(1-2):115-25. PubMed ID: 18314131 [TBL] [Abstract][Full Text] [Related]
34. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Santarlasci V; Maggi L; Capone M; Frosali F; Querci V; De Palma R; Liotta F; Cosmi L; Maggi E; Romagnani S; Annunziato F Eur J Immunol; 2009 Jan; 39(1):207-15. PubMed ID: 19130583 [TBL] [Abstract][Full Text] [Related]
35. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ Nat Immunol; 2007 Dec; 8(12):1390-7. PubMed ID: 17994024 [TBL] [Abstract][Full Text] [Related]
36. Targeting the development and effector functions of TH17 cells. Ghilardi N; Ouyang W Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530 [TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic targets along the Th17 pathway. Ouyang W; Filvaroff E; Hu Y; Grogan J Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720 [TBL] [Abstract][Full Text] [Related]
38. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Mucida D; Park Y; Kim G; Turovskaya O; Scott I; Kronenberg M; Cheroutre H Science; 2007 Jul; 317(5835):256-60. PubMed ID: 17569825 [TBL] [Abstract][Full Text] [Related]
39. Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. Moreira-Teixeira L; Resende M; Coffre M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Rogge L; Ruemmele FM; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC J Immunol; 2011 May; 186(10):5758-65. PubMed ID: 21478400 [TBL] [Abstract][Full Text] [Related]
40. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Wang Y; Jia L; Wu CY Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]